Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Repligen
Work at Repligen?
Add yourself to this profile
78
Repligen
Nearly all therapeutic monoclonal antibodies (mAbs) on the market or in development are produced using bioprocessing products manufactured by Repligen
Edit Profile
repligen.com
Technology
>
Biotechnology
Life Sciences
B2c
Founded in
1981
Raised
$4M
More info
Elsewhere
Companies in the same industry
Agilent Technologies
PATHSENSORS
OPE Group
C4X Discovery Ltd
Karius, Inc.
Helicos BioSciences
Lyncean Technologies Inc.
Cellectis
Annexon Biosciences
Akeso Biomedical, Inc.
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
Venture capital
$4,000,000
Employees
Team size
50+
Locations
Unknown
Help us complete this profile
The Motley Fool
Read This Before You Sell Repligen Corporation Stock
The Motley Fool
Repligen Corporation Jumped 14.6% in February -- Here's Why
The Motley Fool
Why Repligen Corporation Shares Are Falling --
Agilent Technologies
PATHSENSORS
OPE Group
C4X Discovery Ltd
Karius, Inc.
Helicos BioSciences
Lyncean Technologies Inc.
Cellectis
Akeso Biomedical, Inc.